Imricor Medical Systems (ASX:IMR) submitted its Advantage-MR EP Recorder/Stimulator system for US Food and Drug Administration market clearance, according to a Friday filing with the Australian bourse.
The system incorporates a pacemaker for diagnostic cardiac stimulation during electrophysiological evaluations of the heart, the filing said.